Acadian Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Acadian Asset Management's CNMD Position: Q1 2026 in Review
Acadian Asset Management increased its CONMED (CNMD) stake by 459% in Q1 2026, buying an estimated $2.36M and bringing the position to 70,710 shares worth $2.5M. The position accounts for ﹤0.01% of the portfolio, ranked #898.
Acadian Asset Management first reported a position in CNMD in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.53M in Q2 2020. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Acadian Asset Management held 70,710 shares of CONMED worth $2.5M as of Q1 2026.
- Acadian Asset Management bought 58,066 CONMED shares in Q1 2026, an estimated $2.36M.
- CONMED made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #898 holding.
- Acadian Asset Management first reported a position in CONMED in Q2 2013 and has held it in 18 quarters since.
- Acadian Asset Management's CONMED position peaked at $3.53M in Q2 2020.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.